Safety Concerns Affirmed With HCQ in COVID-19
]]>(MedPage Today) -- QT interval prolongation remained a safety concern with hydroxychloroquine (HCQ) for COVID-19 in reports from Boston and France, highlighting the need for careful monitoring.Risk was particularly elevated when HCQ was administered...
Read more »